U.S. Capital Markets Stock News

Vicor buyback completion puts recent trading in context Vicor (VICR) recently updated investors on its share repurchase activity, confirming that from April 1 to June 30, 2026 it bought back no additional shares under its existing authorization. This update means Vicor has now completed repurchases of 805,324 shares, equal to 1.79% of its stock, for a total outlay of US$35.92 million under the buyback first announced on July 31, 2024. See our latest analysis for Vicor. At a last close of...

Why Realty Income’s latest earnings matter now Realty Income (O) has just reported second quarter 2026 results alongside a fresh follow on equity offering, giving investors new information on its rental income, earnings profile and funding plans. See our latest analysis for Realty Income. At a share price of $62.51, Realty Income’s recent 7 day share price return of 1.53% and 30 day share price return of 1.26% both declined. However, its year to date share price return of 9.07% and 1 year...

On August 4, 2026, Ultragenyx Pharmaceutical Inc. reported Q2 2026 results, with revenue of US$214 million versus US$167 million a year earlier and a quarterly net loss of US$92 million versus US$115 million, while first-half 2026 revenue reached US$350 million and net loss was US$277 million. The results showed quarterly revenue growth and a narrower quarterly net loss, while the unchanged first-half loss per share highlights how ongoing investment and spending are still weighing on overall...

Oil giants such as ExxonMobil and Shell sit on nearly $90b in cash after Q2 profits reached a record $48b during the latest flare up in US Iran hostilities. That mix of rich balance sheets, political scrutiny, and uncertain future earnings creates both opportunity and risk. This article walks through 3 large cap energy stocks exposed to this news so you can evaluate which may warrant a closer look at this time. The stocks covered below are just a starting sample, and the full screen surfaced...

In early August 2026, Viatris Inc. reported higher second-quarter and year-to-date revenues, a six-month return to net income, raised its full-year 2026 revenue guidance midpoint to US$14.75 billion, completed a US$1.15 billion share repurchase program covering 8.7% of shares, affirmed a US$0.12 quarterly dividend, and highlighted recent FDA approval of its low-estrogen Gwyn Lo contraceptive patch. Taken together, these updates point to a company using cash flows to retire shares and sustain...

Microsoft (NasdaqGS:MSFT) is expanding its presence in the global digital twin healthcare market, according to a new industry report released in 2026. The report cites Microsoft's product development in AI driven healthcare simulation platforms as a key factor in its position in this segment. Partnerships with healthcare providers and technology companies are described as central to Microsoft's role in digital twin adoption across clinical and operational use cases. The findings highlight a...

HCA Healthcare has reshaped its senior leadership, with Michael Schlosser, M.D., becoming executive vice president and chief clinical officer and Charles Gressle taking charge of the new Ambulatory Operations Group, while Dr. Michael Cuffe transitions to an executive consultant role through February 2027. By consolidating responsibility for clinical quality, digital transformation, and a network of more than 2,700 ambulatory sites under new leaders, HCA Healthcare is tightening oversight of...

Atlassian (TEAM) drew fresh attention after reporting fourth quarter revenue of US$1.77b and net income of US$139.08m, alongside full year results and new revenue guidance for fiscal 2027. See our latest analysis for Atlassian. Atlassian's latest earnings and new revenue outlook arrived alongside a sharp shift in sentiment, with a 1-day share price return of 35.31% and a 30-day share price return of 67.76% suggesting powerful short term momentum. However, a 5-year total shareholder return...

FormFactor, Inc. recently reported past second-quarter 2026 results showing sales of US$258.24 million and net income of US$56.21 million, issued upbeat third-quarter guidance, expanded its Keystone Microtech partnership in Taiwan’s semiconductor hub, and filed a US$544 million shelf registration for 5,000,000 common shares tied to an ESOP-related offering. Together, the stronger profitability, clearer earnings outlook, and deeper manufacturing and support presence in a key semiconductor...

Dividend announcement puts fresh focus on Navios Maritime Partners Navios Maritime Partners (NMM) is back on income investors radar after its board declared a quarterly cash distribution of $0.06 per unit, with an ex dividend date set for August 10, 2026. The decision corresponds to an annualized distribution of $0.24 per unit, with the cash payout scheduled for August 13, 2026 to unitholders of record as of August 10, 2026. See our latest analysis for Navios Maritime Partners. Navios...

Tariff refunds worth US$100b are set to flow back to US importers and retailers after a Supreme Court ruling wiped out a key set of Trump era emergency tariffs. That kind of cash reshuffle can change how certain stocks behave and how investors think about them. This article walks through three stocks exposed to the news and explains why their next moves could matter for your portfolio. The stocks covered below are just a starting sample, and the full screen surfaced 11 more US importers and...

Zoetis Inc. recently reported past second-quarter 2026 results showing largely flat sales at US$2,468 million and a decline in net income to US$691 million, while also lowering its full-year 2026 revenue and diluted EPS guidance amid softer companion-animal demand and increased competition. At the same time, Zoetis moved to reshape its leadership by appointing experienced life sciences executive James (Jay) Saccaro as Executive Vice President, Chief Financial Officer, and Chief Operating...

Eos Energy Enterprises (EOSE) stock is back in focus after the company tightened its 2026 revenue guidance to US$300 million to US$350 million and released second quarter results showing higher revenue alongside continued quarterly net losses. See our latest analysis for Eos Energy Enterprises. The latest guidance update and second quarter results land after a volatile stretch for Eos Energy Enterprises. The stock’s 1-day share price return of 5.33% and 7-day share price return of 10.67%...

UL Solutions (ULS) stock is in focus after the company reported second quarter 2026 earnings, with sales of US$816 million and net income of US$246 million, and reaffirmed its full year outlook. See our latest analysis for UL Solutions. Despite strong Q2 figures and reaffirmed guidance, UL Solutions’ recent share price return has been weak, with the stock down 14.1% over the past week and 19.6% over 90 days, while the 1 year total shareholder return of 18.9% points to longer term gains and...

In the second quarter of 2026, NextDecade Corporation reported a higher net loss of US$65.43 million and increased loss per share, and also filed a US$31.70 million shelf registration for up to 5,000,000 shares of common stock under an ESOP-related offering. The combination of widening losses over the first half of 2026 and a new equity shelf highlights how NextDecade is balancing capital needs for its LNG build-out with the risk of additional shareholder dilution. We’ll now examine how the...

Blackstone stock has delivered a strong 53.9% gain over the past three years. However, both the intrinsic value estimate from the Excess Returns model and the market multiple checks currently point to the shares trading at a premium rather than as a clear bargain. Over the last three years Blackstone has returned 53.9%, which puts recent share price weakness over the past year into the context of a longer run of strong gains. New capital commitments and deals such as AI infrastructure...

Coty stock has had a difficult few years, with the share price well below where it was three years ago, yet the current valuation checks still lean toward the shares looking inexpensive. For investors, that mix of weak long term returns and a high value score raises the question of whether the market is being too pessimistic about Coty or whether the discount reflects real business risks. Coty shareholders have seen the stock fall 76.2% over the last three years, which signals that the...

In recent commentary, analysts flagged ongoing concerns about MongoDB’s business quality, pointing to an inefficient customer acquisition cost payback period and still-negative operating margins despite some improvement. This critique highlights a tension between MongoDB’s long-term platform ambitions and the near-term challenge of converting growth investments into sustainable profitability. We’ll now explore how analysts’ concerns about inefficient customer acquisition costs may reshape...

Why Corpay’s latest earnings and guidance matter for investors Corpay (CPAY) has put itself firmly on investors’ radar after reporting second quarter 2026 results, raising both third quarter and full year guidance, and drawing fresh attention from research analysts. The company reported second quarter sales of US$1,338.81 million compared with US$1,102.03 million a year earlier, while net income for the period was US$248.31 million compared with US$284.17 million in the prior year quarter. On...

Piper Sandler Companies has reported past second-quarter 2026 results showing revenue of US$496.25 million and net income of US$67.85 million, with both metrics higher than a year earlier and earnings per share rising on a basic and diluted basis. Alongside this profit growth, the firm continued to return capital via a US$0.20 quarterly dividend and recently completed a US$92.08 million share repurchase tranche covering 1.35% of its stock. We’ll now examine how this stronger quarterly...

Why Sharplink’s latest earnings and ETH fund launch matter for shareholders The recent move in Sharplink (SBET) stock is closely tied to two fresh developments. The company reported Q2 2026 results alongside the launch of the Galaxy Sharplink Onchain Yield Fund, both centered on its Ethereum focused treasury model. See our latest analysis for Sharplink. Sharplink’s recent news sits against a mixed backdrop for investors, with a 16.7% 1 month share price return and a 3.4% 7 day share price...

With PCE inflation holding above 2% for years and traders now bracing for possible Fed rate hikes into 2027, the cost of money is back in the spotlight. That creates both potential winners and losers across US banks and financial services stocks exposed to this policy shift. This article walks through three stocks from the screener that appear positioned to benefit and explains what their profiles might mean for your portfolio decisions. The three stocks highlighted below are only a sample...

Executive change puts CarMax stock in focus CarMax (KMX) is back on investors' radar after the company announced that Executive Vice President and Chief Innovation and People Officer Diane Cafritz will leave at the end of 2026, with a short consulting period extending into mid 2027. See our latest analysis for CarMax. The leadership update lands at a time when CarMax’s share price has been strong over shorter periods, with a 30 day share price return of 8.77% and a 90 day share price return...

In early August 2026, Health Canada authorized Moderna to begin a Phase I clinical trial of its Bundibugyo virus (Ebola) mRNA vaccine candidate, making Canada the second country after the U.K. to clear first-in-human testing focused on safety, dosing and immune response. This early-stage authorization, in an area with no licensed Bundibugyo vaccine or treatment, underscores Moderna’s push to extend its mRNA platform beyond seasonal respiratory vaccines into high-need infectious...